Aspire Biopharma Holdings Inc
Research Aspire Biopharma Holdings Inc (ASBP) on Bullrun: market cap USD 10.71M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerASBP
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 10.71M
- Financial periodQ1 2026
- RevenueUSD 34.56K
- Net income-USD 11.76M
- Free cash flow-USD 6.21M
- Gross margin16.3%
Valuation Snapshot
latest market cap is USD 10.71M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 6.20K | -USD 24.48M | -USD 4.92M | -1.9% | -16.38 | USD 1.00M | USD 5.18M | -USD 6.38M |
| FY2024 | USD 0 | -USD 1.31M | -USD 265.19K | n/a | -1.9 | USD 3.63K | USD 1.27M | -USD 1.54M |
| FY2023 | n/a | USD 4.46M | n/a | n/a | n/a | USD 11.17K | USD 360.64K | -USD 487.86K |
| FY2022 | n/a | USD 3.34M | n/a | n/a | n/a | USD 497.26K | n/a | -USD 9.94M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 10.71M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 18.66M | n/a | n/a | n/a |
| 2024 | 2024-06-28 | n/a | 464.7 | n/a | n/a |
| 2023 | 2023-12-29 | n/a | 56.9 | n/a | n/a |
| 2022 | 2022-12-30 | n/a | 358.3 | n/a | n/a |
About Aspire Biopharma Holdings Inc
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aspire Biopharma Holdings Inc's market cap?
Aspire Biopharma Holdings Inc's market capitalization is USD 10.71M.
What does Aspire Biopharma Holdings Inc do?
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product.